EyePoint, Inc. 8-K

What Happened

• On April 13, 2026, EyePoint, Inc. announced via Form 8‑K (Item 8.01) that it posted an updated investor presentation on its website (www.eyepoint.bio). The presentation was filed with the SEC as Exhibit 99.1 and is incorporated by reference into the filing. The report was signed by George O. Elston, Executive Vice President and Chief Financial Officer.

Key Details

• Filing date: April 13, 2026 (Form 8‑K, Item 8.01 and Item 9.01).
• Presentation posted at www.eyepoint.bio and submitted to the SEC as Exhibit 99.1 (Investor Presentation dated April 13, 2026).
• Form 8‑K was signed by George O. Elston, EVP & CFO.
• The filing includes the standard Cover Page Interactive Data File (Exhibit 104) embedded in the XBRL document.

Why It Matters

• The updated investor presentation is now part of EyePoint’s public SEC record and provides investors a current source for the company’s corporate, program, and financial messaging. While the 8‑K does not itself disclose earnings or new financial results, investors should review the posted presentation for any refreshed guidance, clinical progress, or strategic updates that could affect valuation or investment decisions.